Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUVOREXANT vs TACROLIMUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUVOREXANT vs TACROLIMUS: Safety Overview

Metric SUVOREXANT TACROLIMUS
Total FAERS Reports 9,413 91,009
Deaths Reported 219 14,642
Death Rate 2.3% 16.1%
Hospitalizations 572 36,664
Average Patient Age 62.6 yrs 46.7 yrs
% Female Patients 62.4% 44.1%
FDA Approval Date Aug 13, 2014 Apr 16, 2018
Manufacturer Merck Sharp & Dohme LLC Strides Pharma Science Limited
Route ORAL ORAL
Marketing Status Prescription Prescription